Cover Image

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis

Background: Meropenem is being investigated for repurposing as an anti-tuberculosis drug. This study aimed to develop a meropenem population pharmacokinetics model in patients with pulmonary tuberculosis and identify covariates explaining inter-individual variability.Methods: Patients were randomize...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ahmed A. Abulfathi (Author), Veronique de Jager (Author), Elana van Brakel (Author), Helmuth Reuter (Author), Nikhil Gupte (Author), Naadira Vanker (Author), Grace L. Barnes (Author), Eric Nuermberger (Author), Susan E. Dorman (Author), Andreas H. Diacon (Author), Kelly E. Dooley (Author), Elin M. Svensson (Author)
Format:	Book
Published:	Frontiers Media S.A., 2021-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Pharmacometrics-tools to assure optimal medicine use in low- and middle-income countries
by: Ahmed A. Abulfathi, et al.
Published: (2022)

Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development
by: Rami Ayoun Alsoud, et al.
Published: (2023)

Laboratory test result interpretation for primary care doctors in South Africa
by: Naadira Vanker, et al.
Published: (2017)

Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin
by: Lina Keutzer, et al.
Published: (2022)

Seasonal influence on respiratory tract infection severity including COVID‐19 quantified through Markov Chain modeling
by: Rob C. vanWijk, et al.
Published: (2023)

Household contact management for rifampicin-resistant tuberculosis
by: Anja Reuter, et al.
Published: (2022)

Exposure-safety analysis of QTc interval and transaminase levels following bedaquiline administration in patients with drug‐resistant tuberculosis
by: Lénaïg Tanneau, et al.
Published: (2021)

The effect of rifampicin and isoniazid on liver and lung tissues in rats
by: Dalal F. Ahmed
Published: (2011)

Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development
by: Laurynas Mockeliunas, et al.
Published: (2023)

Optimizing the design of a pharmacokinetic trial to evaluate the dosing scheme of a novel tuberculosis drug in children living with or without HIV
by: Grace Montepiedra, et al.
Published: (2024)

Does gender matter? The association between different digital media activities and adolescent well-being
by: Robert Svensson, et al.
Published: (2022)

Evaluation of the genexpert Mycobacterium tuberculosis/Rifampicin assay for early detection of extrapulmonary tuberculosis and rifampicin resistance in aligarh region of Northern India
by: M D Ahsan Imam, et al.
Published: (2023)

Age-appropriate vaccination and its determinants among children <24 months in Kano, Nigeria
by: Hajara I Maizare, et al.
Published: (2023)

Rifampicin induced thrombocytopenia
by: Das Sudip, et al.
Published: (2006)

Formulation of Rifampicin Suspension
by: Lubna A. Sabri, et al.
Published: (2017)

Formulation of Rifampicin Suspension
by: Lubna A. Sabri, et al.
Published: (2017)

Peelable Nanocomposite Coatings: "Eco-Friendly" Tools for the Safe Removal of Radiopharmaceutical Spills or Accidental Contamination of Surfaces in General-Purpose Radioisotope Laboratories
by: Traian Rotariu, et al.
Published: (2022)

Pharmacometrics meets statistics-A synergy for modern drug development
by: Yevgen Ryeznik, et al.
Published: (2021)

A population pharmacokinetics analysis assessing the exposure of raltegravir once‐daily 1200 mg in pregnant women living with HIV
by: Vera E. Bukkems, et al.
Published: (2021)

Familial steatocystoma multiplex generalisita suppuritiva: Oral rifampicin and clindamycin combination worth a trial
by: Ghazal Ahmed, et al.
Published: (2021)

Meropenem pharmacokinetics in children: series of cases
by: Geisa Cristina da Silva Alves, et al.
Published: (2018)

Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of in vitro, in vivo methodologies and human studies
by: Jan-Willem C. Alffenaar, et al.
Published: (2022)

Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis
by: Myo T. Zaw, et al.
Published: (2018)

Power to identify exposure‐response relationships in phase IIa pulmonary tuberculosis trials with multi‐dimensional bacterial load modeling
by: Simon E. Koele, et al.
Published: (2024)

Clinical Outcomes and Safety of Meropenem-Colistin versus Meropenem-Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021)

An investigation of the stability of meropenem in elastomeric infusion devices
by: Foy F, et al.
Published: (2019)

The effect of oral clindamycin and rifampicin combination therapy in patients with hidradenitis suppurativa in Singapore
by: Ochi H, et al.
Published: (2018)

An impact of CYP3A4 *1B polymorphism on rifampicin metabolism
by: H. O. Poludenko, et al.
Published: (2017)

An impact of CYP3A4 *1B polymorphism on rifampicin metabolism
by: H. O. Poludenko, et al.
Published: (2017)

Effect of Interindividual Variability in Metabolic Clearance and Relative Bioavailability on Rifampicin Exposure in Tuberculosis Patients with and without HIV Co-Infection: Does Formulation Quality Matter?
by: Glauco Henrique Balthazar Nardotto, et al.
Published: (2024)

Big Digital Humanities
by: Patrik Svensson
Published: (2016)

Big Digital Humanities: Imagining a Meeting Place for the Humanities and the Digital
by: Svensson, Patrik
Published: (2016)

Big Digital Humanities: Imagining a Meeting Place for the Humanities and the Digital
by: Svensson, Patrik
Published: (2016)

Could painful temporomandibular disorders be nociplastic in nature? A critical review and new proposal
by: Peter Svensson
Published: (2024)

Victim Support in a Changing Welfare State
by: Kerstin Svensson
Published: (2007)

Exploring patient safety risk in an emergency ward for substance use through a mixed-method analysis
by: Jakob Svensson
Published: (2024)

Sustainability of long-term treatment in a rural district: The Lusikisiki model of decentralised HIV/AIDS care
by: Nathan Ford, et al.
Published: (2006)

Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers
by: Shin Y, et al.
Published: (2022)

Composition Influence on Pulmonary Delivery of Rifampicin Liposomes
by: Maria Letizia Manca, et al.
Published: (2012)

Development and Characterization of Pharmaceutical Systems Containing Rifampicin
by: Antonella V. Dan Córdoba, et al.
Published: (2023)